ISRG has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ISRG has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Intuitive Surgical's annualized ROCE % for the quarter that ended in Dec. 2024 was 17.78%.
The historical data trend for Intuitive Surgical's ROCE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intuitive Surgical Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
ROCE % | Get a 7-Day Free Trial |
![]() |
![]() |
11.11 | 16.11 | 13.17 | 13.95 | 15.26 |
Intuitive Surgical Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
ROCE % | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
13.43 | 13.30 | 15.32 | 14.79 | 17.78 |
Intuitive Surgical's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:
ROCE % | = | EBIT | / | ( (Capital Employed | + | Capital Employed) | / count ) |
(A: Dec. 2024 ) | (A: Dec. 2023 ) | (A: Dec. 2024 ) | |||||
= | EBIT | / | ( ( (Total Assets - Total Current Liabilities) | + | (Total Assets - Total Current Liabilities) ) | / count ) | |
(A: Dec. 2024 ) | (A: Dec. 2023 ) | (A: Dec. 2024 ) | |||||
= | 2348.9 | / | ( ( (15441.5 - 1658.7) | + | (18743.2 - 1745.3) ) | / 2 ) | |
= | 2348.9 | / | ( (13782.8 | + | 16997.9) | / 2 ) | |
= | 2348.9 | / | 15390.35 | ||||
= | 15.26 % |
Intuitive Surgical's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:
ROCE % | = | EBIT (1) | / | ( (Capital Employed | + | Capital Employed) | / count ) |
(Q: Dec. 2024 ) | (Q: Sep. 2024 ) | (Q: Dec. 2024 ) | |||||
= | EBIT | / | ( ( (Total Assets - Total Current Liabilities) | + | (Total Assets - Total Current Liabilities) ) | / count ) | |
(Q: Dec. 2024 ) | (Q: Sep. 2024 ) | (Q: Dec. 2024 ) | |||||
= | 2939.6 | / | ( ( (17743.4 - 1676.8) | + | (18743.2 - 1745.3) ) | / 2 ) | |
= | 2939.6 | / | ( ( 16066.6 | + | 16997.9 ) | / 2 ) | |
= | 2939.6 | / | 16532.25 | ||||
= | 17.78 % |
(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intuitive Surgical (NAS:ISRG) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
Thank you for viewing the detailed overview of Intuitive Surgical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.
Gary Loeb | officer: General Counsel & CCO | 5885 HOLLIS ST., SUITE 100, EMERYVILLE CA 94608 |
Myriam Curet | officer: SVP & Chief Medical Officer, other: SVP & Chief Medical Officer | 1020 KIFER ROAD, SUNNYVALE CA 94086 |
Jamie Samath | officer: Chief Accounting Officer | NATIONAL SEMICONDUCTOR, 2900 SEMICONDUCTOR DR, M/S C1-640, SANTA CLARA CA 95051 |
Amal M Johnson | director | C/O MELLANOX TECHNOLOGIES, INC., 350 OAKMEAD PARKWAY, SUITE 100, SUNNYVALE CA 94085 |
Amy L Ladd | director | INTUITIVE SURGICAL, INC, 1020 KIFER RD, SUNNYVALE CA 94086 |
Robert Desantis | officer: Executive VP & GM IA&E | C/O INTUITIVE SURGICAL, INC., 1020 KIFER ROAD, SUNNYVALE CA 94086 |
Gary S Guthart | director, officer: President & CEO, other: President & CEO | C/O INTUITIVE SURGICAL INC, 1266 KIFER RD, SUNNYVALE CA 94086 |
Henry L Charlton | officer: Senior Vice President & Chief | 1020 KIFER ROAD, 1020 KIFER ROAD, SUNNYVALE CA 94086 |
Craig H Barratt | director | |
Mark J Rubash | director | |
Alan J Levy | director | C/O INTUITIVE SURGICAL INC, 1266 KIFER RD, SUNNYVALE CA 94086 |
Fredrik Widman | officer: VP Corporate Controller | 1020 KIFER ROAD, 1020 KIFER ROAD, SUNNYVALE CA 94086 |
Marshall Mohr | officer: SVP & CFO | C/O INTUITIVE SURGICAL, INC, 1266 KIFER ROAD, SUNNYVALE CA 94086 |
David J. Rosa | officer: Sr VP Emerging Procedures & Te | 1266 KIFER ROAD, SUNNYVALE CA 94086 |
Sreelakshmi Kolli | director | C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131 |
From GuruFocus
By GuruFocus News • 01-15-2025
By Marketwired • 01-21-2025
By GuruFocus News • 01-24-2025
By GuruFocus News • 01-29-2025
By GuruFocus News • 01-15-2025
By GuruFocus News • 01-15-2025
By GuruFocus News • 01-24-2025
By GuruFocus News • 01-21-2025
By GuruFocus News • 01-29-2025
By Faizan Farooque • 01-21-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.